These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 6774537)

  • 21. Pathophysiology of L-dopa-induced dyskinesias.
    Bédard PJ; Blanchet PJ; Lévesque D; Soghomonian JJ; Grondin R; Morissette M; Goulet M; Calon F; Falardeau P; Gomez-Mancilla B; Doucet JP; Robertson GS; DiPaolo T
    Mov Disord; 1999; 14 Suppl 1():4-8. PubMed ID: 10493397
    [No Abstract]   [Full Text] [Related]  

  • 22. Brain nervous mechanisms involved in the so-called extra pyramidal motor and psychomotor disturbances.
    Poirier L; Filion M; Langelier P; Larochelle L
    Prog Neurobiol; 1975; 5(3):197-243. PubMed ID: 242037
    [No Abstract]   [Full Text] [Related]  

  • 23. Neurohumoral interactions and basal ganglia function and dysfunction.
    Hornykiewicz O
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():269-80. PubMed ID: 12547
    [No Abstract]   [Full Text] [Related]  

  • 24. CGP 56999A, a GABA(B) receptor antagonist, enhances expression of brain-derived neurotrophic factor and attenuates dopamine depletion in the rat corpus striatum following a 6-hydroxydopamine lesion of the nigrostriatal pathway.
    Enna SJ; Reisman SA; Stanford JA
    Neurosci Lett; 2006 Oct; 406(1-2):102-6. PubMed ID: 16890350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
    Yamamoto BK; Nash JF; Gudelsky GA
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1063-70. PubMed ID: 7791076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Striatal dysfunction increases basal ganglia output during motor cortex activation in parkinsonian rats.
    Belluscio MA; Riquelme LA; Murer MG
    Eur J Neurosci; 2007 May; 25(9):2791-804. PubMed ID: 17561844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropeptide co-release with GABA may explain functional non-monotonic uncertainty responses in dopamine neurons.
    Tan CO; Bullock D
    Neurosci Lett; 2008 Jan; 430(3):218-23. PubMed ID: 18053647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine and extrapyramidal motor function and dysfunction.
    Hornykiewicz O
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():390-415. PubMed ID: 4561070
    [No Abstract]   [Full Text] [Related]  

  • 29. The basal ganglia in extrapyramidal dysfunction.
    Barnes CD
    Brain Res Bull; 1983 Aug; 11(2):271-5. PubMed ID: 6226339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychoactive agents in dogs with bilateral lesions in subcortical structures.
    Goldstein S; Himwich WA; Leiner K; Stout M
    Neurology; 1971 Aug; 21(8):847-52. PubMed ID: 5315220
    [No Abstract]   [Full Text] [Related]  

  • 31. Symptomatic or secondary basal ganglia diseases and tardive dyskinesias.
    Berardelli A
    Curr Opin Neurol; 1995 Aug; 8(4):320-2. PubMed ID: 7582050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dopaminergic conception of Parkinsonism and its treatment with L-DOPA].
    Levin SL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(9):1418-26. PubMed ID: 4349303
    [No Abstract]   [Full Text] [Related]  

  • 33. Intrastriatal administration of human immunodeficiency virus-1 glycoprotein 120 reduces glial cell-line derived neurotrophic factor levels and causes apoptosis in the substantia nigra.
    Nosheny RL; Bachis A; Aden SA; De Bernardi MA; Mocchetti I
    J Neurobiol; 2006 Oct; 66(12):1311-21. PubMed ID: 16967504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pure autonomic failure with altered dopamine transporter imaging.
    Compta Y; Martí MJ; Paredes P; Tolosa E
    Arch Neurol; 2006 Apr; 63(4):604-5. PubMed ID: 16606777
    [No Abstract]   [Full Text] [Related]  

  • 35. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
    Hossain MA; Weiner N
    J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extrapyramidal motor symptoms versus striatal infarction volume after focal ischemia in mongolian gerbils.
    Ishibashi S; Kuroiwa T; Katsumata N; Yuan SL; Endo S; Mizusawa H
    Neuroscience; 2004; 127(2):269-75. PubMed ID: 15262318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the caudate nucleus in production of dyskinesia [proceedings].
    Matsumoto Y; Mino S; Yoshimura Y; Asano T; Mimura Y; Ohmoto T; Nishimoto A
    Appl Neurophysiol; 1979; 42(5):313-4. PubMed ID: 518065
    [No Abstract]   [Full Text] [Related]  

  • 38. Dystonia musculorum deformans: a 'critical phenomenon' model involving nigral dopaminergic and caudate pathways.
    Kelleher JF; Mandell AJ
    Med Hypotheses; 1990 Jan; 31(1):55-8. PubMed ID: 2179685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic activity of cerebellar and basal ganglia-thalamic neurons is reduced in parkinsonism.
    Rolland AS; Herrero MT; Garcia-Martinez V; Ruberg M; Hirsch EC; François C
    Brain; 2007 Jan; 130(Pt 1):265-75. PubMed ID: 17148469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain DOPA-5-HTP decarboxylase activity after the chronic administration of L-dopa or 5-hydroxy-L-tryptophan in normal and lesioned cats.
    Roberge AG; Poirier LJ
    Brain Res; 1974 Aug; 76(3):401-12. PubMed ID: 4546739
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.